These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29095275)

  • 1. Muscle ultrasound: A useful tool in newborn screening for infantile onset pompe disease.
    Hwang HE; Hsu TR; Lee YH; Wang HK; Chiou HJ; Niu DM
    Medicine (Baltimore); 2017 Nov; 96(44):e8415. PubMed ID: 29095275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.
    Yang CF; Liu HC; Hsu TR; Tsai FC; Chiang SF; Chiang CC; Ho HC; Lai CJ; Yang TF; Chuang SY; Lin CY; Niu DM
    Am J Med Genet A; 2014 Jan; 164A(1):54-61. PubMed ID: 24243590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease.
    Lin N; Huang J; Violante S; Orsini JJ; Caggana M; Hughes EE; Stevens C; DiAntonio L; Chieh Liao H; Hong X; Ghomashchi F; Babu Kumar A; Zhou H; Kornreich R; Wasserstein M; Gelb MH; Yu C
    Clin Chem; 2017 Apr; 63(4):842-851. PubMed ID: 28196920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two new mutations in the gene that codes for acid alpha-glucosidase in an adolescent with late-onset Pompe disease].
    Guevara-Campos J; Romeo-Villarroel MA; González-De Guevara L; Escobar V
    Rev Neurol; 2013 Sep; 57(6):265-8. PubMed ID: 24008937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
    Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA
    Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease.
    Tortorelli S; Eckerman JS; Orsini JJ; Stevens C; Hart J; Hall PL; Alexander JJ; Gavrilov D; Oglesbee D; Raymond K; Matern D; Rinaldo P
    Genet Med; 2018 Aug; 20(8):840-846. PubMed ID: 29095812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pompe disease: early diagnosis and early treatment make a difference.
    Chien YH; Hwu WL; Lee NC
    Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening.
    Lukacs Z; Nieves Cobos P; Mengel E; Hartung R; Beck M; Deschauer M; Keil A; Santer R
    J Inherit Metab Dis; 2010 Feb; 33(1):43-50. PubMed ID: 20033296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in late and lost: Pediatricians' role in following Pompe disease identified by newborn screening.
    Pillai NR; Fabie NAV; Kaye TV; Rosendahl SD; Ahmed A; Hietala AD; Jorgenson AB; Lanpher BC; Whitley CB
    Mol Genet Metab; 2023; 140(1-2):107633. PubMed ID: 37414610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.
    Young SP; Zhang H; Corzo D; Thurberg BL; Bali D; Kishnani PS; Millington DS
    Genet Med; 2009 Jul; 11(7):536-41. PubMed ID: 19521244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.
    Peng SS; Hwu WL; Lee NC; Tsai FJ; Tsai WH; Chien YH
    Orphanet J Rare Dis; 2016 May; 11(1):63. PubMed ID: 27183828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth.
    Chien YH; Lee NC; Chen CA; Tsai FJ; Tsai WH; Shieh JY; Huang HJ; Hsu WC; Tsai TH; Hwu WL
    J Pediatr; 2015 Apr; 166(4):985-91.e1-2. PubMed ID: 25466677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of lactate dehydrogenase, creatine kinase and hepatic enzymes for the retrospective diagnosis of perinatal asphyxia among sick neonates.
    Reddy S; Dutta S; Narang A
    Indian Pediatr; 2008 Feb; 45(2):144-7. PubMed ID: 18310795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease.
    Wang Z; Okamoto P; Keutzer J
    Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for late-onset Pompe disease in Finland.
    Palmio J; Auranen M; Kiuru-Enari S; Löfberg M; Bodamer O; Udd B
    Neuromuscul Disord; 2014 Nov; 24(11):982-5. PubMed ID: 25047669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.
    Preisler N; Lukacs Z; Vinge L; Madsen KL; Husu E; Hansen RS; Duno M; Andersen H; Laub M; Vissing J
    Mol Genet Metab; 2013 Nov; 110(3):287-9. PubMed ID: 24011652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry.
    Dajnoki A; Mühl A; Fekete G; Keutzer J; Orsini J; Dejesus V; Zhang XK; Bodamer OA
    Clin Chem; 2008 Oct; 54(10):1624-9. PubMed ID: 18703766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.